B型CpG寡核苷酸 – 人源优先 TLR9 配体
CpG ODNs 是合成的寡核苷酸，包含一段特定的非甲基化CpG核苷酸（CpG motifs）。这些CpG motifs在细菌DNA中出现的频率是哺乳动物DNA的20倍。CpG ODNs可被Toll-like receptor 9 (TLR9)识别，产生强效免疫调节效果。
ODN 2006是B型CpG ODN，倾向于激活人源TLR9。B型CpG ODN全部由硫代磷酸二酯键骨架构成，含有一个或多个CpG核苷酸。B型CpG ODN是B细胞的强活化剂，但是刺激浆样树突细胞分泌IFN-α的能力却很弱。
| ODN 2006 Vaccigrade™ | TLR9 刺激物 – CpG ODN, class B (人源优先) | 诱导Th1 反应 | 1 mg |
| ODN 2006 (ODN 7909) | TLR9 Agonist – Stimulatory CpG ODN, Class B, Human preferred | 200 µg 1 mg 5 mg |
| ODN 2006 control (ODN 2137) | ODN 2137 : Negative control for ODN 2006 | 200 µg 1 mg 5 mg |
| ODN 2006 Biotin | TLR9 Agonist – Biotin-labelled CpG ODN 2006, Class B, Human preferred | 2 x 50 µg |
| ODN 2006 FITC | TLR9 Agonist – FITC-labelled CpG ODN 2006, Class B, Human preferred | 50 µg |
| ODN 2006-G5 | TLR9 Agonist – Stimulatory CpG ODN, Class B, Human preferred | 200 µg 1 mg 5 mg |
| ODN 2006-G5 control | Negative control for ODN 2006-G5 | 200 µg |
